With an initial emphasis on rapid identification of infectious diseases thereby to improve both the well-being of patient and healthcare economics, Volitylix, Inc., is a healthcare start-up structured to achieve an effective interaction and positive interacton between technology developed at Brigham and Womenâs Hospital and that developed at the Charles Stark Draper Laboratories.
